⚠ Evidence warning: Clinical trials or other evidence do not support the claim that St. John's wort oil speeds the healing of burns, bruises and chronic wounds (pressure, venous and diabetic foot ulcers), clears warts and cervical dysplasia, eases neuralgia and sciatica, and that modern research has substantially validated these traditional uses. This page keeps it as a report of what people, websites or other media say.

St. John's Wort for Antiviral and Wound-Healing Applications

Antiviral and Wound Healing — scientific infographic poster

Long before St. John's Wort became famous as an antidepressant in the 1990s, the herb was renowned throughout European folk medicine as a wound-healing and nerve-soothing topical. The traditional preparation called Oleum Hyperici, "St. John's Oil," or "Red Oil" — fresh hypericum flowers infused in olive oil and sun-cured for several weeks until the oil turned deep crimson with extracted hypericin — was a staple of household medicine cabinets from medieval times through the 19th century. Modern research has substantially validated the traditional indications: hypericin is a potent photodynamic agent generating singlet oxygen under visible light that damages enveloped viral particles (HSV-1, HSV-2, influenza), hyperforin directly disrupts bacterial membranes including those of methicillin-resistant Staphylococcus aureus (MRSA), and the topical oil's combination of anti-inflammatory flavonoids, tannins, and tissue-regenerating activity produces measurably faster epithelialization in burns, bruises, abrasions, and surgical wounds. Hypericin photodynamic therapy (PDT) for HSV cold sores and for certain skin cancers is an area of research, and it has been proposed for anogenital human papillomavirus warts. This deep-dive explores the antiviral mechanisms, the traditional and modern topical applications, the nerve-pain indications (trigeminal neuralgia, post-herpetic neuralgia, sciatica), the bacterial-skin-infection applications including methicillin-resistant Staphylococcus aureus, and the home preparation of traditional infused oil.


Table of Contents

  1. Traditional History — The Wound Oil Predates the Antidepressant
  2. Hypericin Photodynamic Mechanism Against Enveloped Viruses
  3. HSV-1 and HSV-2 (Cold Sores, Genital Herpes)
  4. Human Papillomavirus (Anogenital and Cutaneous Warts) — Topical PDT
  5. Hypericum Light Therapy for Skin Pre-Cancers and Skin Cancer
  6. Influenza, Hepatitis, and Other Enveloped Viruses
  7. Hyperforin Antibacterial — Methicillin-Resistant Staphylococcus Aureus and Skin Pathogens
  8. Wound-Healing Mechanism (Flavonoids, Tannins, Tissue Regeneration)
  9. Burns, Bruises, and Minor Abrasions
  10. Surgical Wound Recovery
  11. Nerve-Pain Applications (Trigeminal Neuralgia, Post-Herpetic Neuralgia, Sciatica)
  12. Home Preparation of Traditional Infused Oil
  13. Topical Cautions and Photosensitivity
  14. Key Research Papers
  15. Connections
  16. Featured Videos

Traditional History — The Wound Oil Predates the Antidepressant

The modern association of Hypericum perforatum with mental health dates only to the late 20th century, but the herb's European medicinal history spans nearly two thousand years — and almost all of that history concerns its topical and wound-care use, not its psychological applications. The first-century Greek physician Dioscorides described hypericum in De Materia Medica as useful for "burns, sciatica, ulcers, and the bites of venomous beasts," recommending the freshly bruised herb applied directly to wounds. Pliny the Elder noted similar uses in his Natural History.

Through the medieval period, hypericum-infused oil (Oleum Hyperici) became a near-universal feature of European household medicine. The Benedictine and Franciscan monasteries cultivated the plant in apothecary gardens and prepared the red oil for treatment of:

By the 17th-19th centuries, hypericum-infused oil was a routine entry in European pharmacopoeias and was carried in the medical kits of military surgeons. The British naval surgeon's manuals listed it for burns from gunpowder accidents and for shrapnel wound aftercare. The traditional knowledge encoded centuries of empirical observation: applied topically, this red oil predictably accelerated healing and reduced pain in a wide range of skin and soft-tissue injuries.

Modern mechanistic research has substantially validated the traditional use. The combination of hypericin (photodynamic antimicrobial and tissue-stimulating effects), hyperforin (anti-inflammatory, antibacterial including methicillin-resistant Staphylococcus aureus, and possibly tissue regenerative), flavonoids (antioxidant and anti-inflammatory), and tannins (astringent and antimicrobial) collectively produces the documented topical effects that European folk medicine had identified empirically over centuries.

Back to Table of Contents

Hypericin Photodynamic Mechanism Against Enveloped Viruses

Hypericin is the principal compound responsible for the antiviral activity of St. John's Wort. The mechanism is photodynamic: hypericin acts as a photosensitizer, absorbing visible light (peak absorption in the 540-610 nm green-yellow-orange range) and transferring that energy to molecular oxygen, generating singlet oxygen (a reactive electronically excited form of O2) and other reactive oxygen species (superoxide, hydroxyl radicals, peroxides).

These reactive oxygen species do not differentiate between host cells and pathogens, but the geometry of the photodynamic interaction strongly favors damage to enveloped viral particles because:

  1. Viral envelope lipids and proteins are particularly susceptible to singlet-oxygen-mediated peroxidation, disrupting the envelope and rendering the virus unable to bind target cells
  2. Viral genomic nucleic acids, once released from the damaged envelope, are degraded by reactive species
  3. The viral genome (a few thousand to a few hundred thousand bases) has many fewer redundant copies than a host cell genome, so any damage is much more functionally consequential
  4. Hypericin preferentially accumulates in the lipid envelope of viral particles due to its lipophilic nature

The result is selective destruction of enveloped viruses while topical host cells — with their robust DNA repair machinery, much larger genome, and antioxidant defenses — experience comparatively limited damage. The pattern is similar to other clinically used photodynamic photosensitizers (porphyrins, phthalocyanines) but with a substantially different photochemistry profile.

Hypericin photodynamic activity has been documented in vitro against a wide range of enveloped viruses including:

Non-enveloped viruses (adenovirus, rotavirus, poliovirus, papillomavirus) are generally less susceptible to hypericin photodynamic inactivation, Topical photodynamic therapy with hypericin has been proposed for human papillomavirus warts, through mechanisms beyond direct viral inactivation such as wart-cell killing, but a PubMed search finds no published clinical study of it.

Back to Table of Contents

HSV-1 and HSV-2 (Cold Sores, Genital Herpes)

Herpes simplex virus is the textbook example of an enveloped virus susceptible to hypericin photodynamic inactivation. Topical hypericum-infused oil and modern hypericin photodynamic preparations have been investigated for:

How traditional hypericum oil is used on HSV lesions:

Modern hypericin photodynamic therapy (PDT) protocols in dermatology research extend the traditional oil application to a more controlled clinical context: a standardized hypericin preparation is applied topically to the lesion, allowed to penetrate for 30-60 minutes, then activated by exposure to a controlled visible light source (typically broad-spectrum visible or specific 590-610 nm wavelength). This produces a more intense and controlled photodynamic effect than ambient-light activation of traditional oil application.

The most established conventional treatments for HSV remain oral antivirals (acyclovir, valacyclovir, famciclovir), which are highly effective and well-tolerated. Hypericum topical use is described as an adjunct, or as an option for people who cannot tolerate or cannot get conventional antiviral therapy; it is not first-line for severe or frequent HSV recurrences. For more on the relevant disease, see our Shingles page (varicella zoster, related to HSV but a distinct virus with its own treatment considerations).

Back to Table of Contents

Human Papillomavirus (Anogenital and Cutaneous Warts) — Topical PDT

Human papillomavirus (HPV) is a non-enveloped virus, and direct hypericin photodynamic inactivation of viral particles is less efficient than for enveloped viruses. Hypericin topical PDT has instead been proposed for human papillomavirus-related warts through a different mechanism — selective destruction of the wart cells themselves rather than direct viral inactivation — but no clinical study of it is published. The proposed mechanism: hypericin preferentially accumulates in proliferating wart-cell tissue, photodynamic activation destroys the wart cells, and the immune system clears the resulting cellular debris and any persistent viral particles.

Hypericin PDT and hypericum oil have been proposed or used for:

For routine human papillomavirus wart management, conventional treatments (cryotherapy, imiquimod 5% cream, podophyllotoxin, salicylic acid for common warts, sinecatechins ointment for genital warts) remain the standard of care. Hypericum topical preparations sit outside that standard; their use on warts rests on folk tradition.

Back to Table of Contents

Hypericum Light Therapy for Skin Pre-Cancers and Skin Cancer

One small human study has tested St. John's wort light therapy on the skin. In a 2008 pilot study of 34 patients — 8 with actinic keratoses (pre-cancerous skin patches), 21 with basal cell carcinoma and 5 with Bowen's disease (a skin carcinoma in situ) — a St. John's wort extract was applied to the lesions under a covering dressing and lit with red light 2 hours later. The treatment was repeated weekly for 6 weeks on average.

The authors wrote that the results “could be regarded as disappointing,” while listing ways the method might be improved (better lesion preparation, better hypericin delivery and other light procedures).

Back to Table of Contents

Influenza, Hepatitis, and Other Enveloped Viruses

The in vitro photodynamic activity of hypericin against influenza, hepatitis B, hepatitis C, and human immunodeficiency virus has been documented in laboratory research but has not translated into established clinical antiviral applications for these systemic infections. The fundamental problem is that effective in vivo systemic antiviral activity would require both adequate hypericin plasma concentrations and adequate light penetration to the tissues where viral replication occurs — and visible light does not penetrate deep tissues effectively. Hypericin photodynamic activity is therefore practically limited to topical and superficial applications where light can reach the infected tissue.

Hypericin has been tested as an antiviral drug in people, with negative results:

Two niches where hypericin antiviral activity may have practical application:

For systemic antiviral applications, conventional antivirals (oseltamivir for influenza, direct-acting antivirals for hepatitis C, combination antiretroviral therapy for human immunodeficiency virus) are highly effective and remain the standard of care. Hypericum oral supplementation does not provide meaningful systemic antiviral activity, and may in fact be contraindicated in human immunodeficiency virus due to its cytochrome P450 3A4 (CYP3A4) induction that reduces antiretroviral drug levels by 50% or more.

Back to Table of Contents

Hyperforin Antibacterial — Methicillin-Resistant Staphylococcus Aureus and Skin Pathogens

Beyond the hypericin photodynamic antiviral activity, hypericum extracts contain hyperforin, which has demonstrated direct antibacterial activity through a different mechanism: hyperforin disrupts bacterial cell membranes by inserting into the lipid bilayer and dissipating the membrane proton gradient that bacteria require for adenosine triphosphate (ATP) synthesis. The activity is most pronounced against Gram-positive bacteria.

The most clinically interesting finding: hyperforin shows potent activity against methicillin-resistant Staphylococcus aureus (MRSA) in vitro, with minimum inhibitory concentrations in the low-micromolar range and bactericidal (not just bacteriostatic) effect. Schempp et al. (1999) and subsequent investigators have characterized this activity in detail. The mechanism is membrane-disruptive rather than target-protein-binding, which is why methicillin-resistant Staphylococcus aureus resistance (mediated by altered penicillin-binding protein PBP2a that confers beta-lactam resistance) does not confer cross-resistance to hyperforin.

Documented hyperforin antibacterial spectrum includes:

Clinical translation of hyperforin antibacterial activity has focused primarily on topical applications:

For serious systemic bacterial infection, oral hypericum is not adequate antibacterial therapy and conventional antibiotic treatment is required. The topical hyperforin antibacterial activity is best understood as a complementary mechanism to the oil's broader wound-healing effects rather than a standalone antibacterial treatment.

Back to Table of Contents

Wound-Healing Mechanism (Flavonoids, Tannins, Tissue Regeneration)

The wound-healing properties of hypericum-infused oil arise from the combined action of multiple compound classes:

The net effect reported for hypericum preparations — with the human trials limited to small studies of ointments after caesarean section and episiotomy (see Surgical Wound Recovery) — is accelerated wound healing characterized by:

A 2026 structured review of St. John's wort for diabetes-related wounds found nine animal studies and three uncontrolled human reports involving St. John's wort–neem (Azadirachta indica) combination products. Most animal studies were at unclear or high risk of bias, and five of the nine lacked a carrier-matched control, so the plant's contribution could not be separated from the carrier oil's. No randomized human trial has established that St. John's wort alone heals diabetes-related wounds; outside diabetes, the human studies ranged from favourable acute surgical-wound trials to a negative randomized pressure-injury trial. The review concluded that clinical efficacy in diabetes-related wounds “remains unproven.”

Back to Table of Contents

Burns, Bruises, and Minor Abrasions

Burns: hypericum oil applied to first-degree (superficial epidermal) and minor second-degree (partial-thickness) burns is a traditional use; the controlled evidence comes from animals. The oil is traditionally applied directly to the burn surface 2-3 times daily after initial cooling and gentle cleansing. Effects reported include:

For severe burns (deep partial-thickness, full-thickness, electrical burns, chemical burns, burns of greater than 10% body surface area, or burns of face/hands/genitalia/major joints), hospitals treat these as emergencies, and hypericum oil is not a first-line treatment for them. For minor home-care burns (small kitchen burns, sunburn, friction burns), hypericum oil is a traditional household remedy.

Bruises and contusions: traditional and modern use of hypericum oil for bruises involves topical massage of the oil into intact skin overlying the contusion. The anti-inflammatory and circulatory-stimulating effects help resolve the bruise more rapidly. The combination of hypericum oil with Arnica (another classic herbal bruise remedy) in topical preparations is common in European phytotherapy. Traditional use is 2-3 applications daily until the bruise resolves.

Minor abrasions and shallow lacerations: traditional use is to apply hypericum oil to the wound surface 2-3 times daily until epithelialized, after gentle cleansing with water rather than vigorous scrubbing or hydrogen peroxide (which damages healing tissue). A non-stick dressing keeps out contamination, particularly for wounds in high-friction or contaminated areas.

Sunburn: a notable paradox in topical use. While oral hypericum can cause photosensitivity reactions, topical hypericum oil applied to sunburned skin has soothing effects, reducing redness and pain and promoting healing. The mechanism likely involves the anti-inflammatory flavonoids dominating over any minor photodynamic effect at the local site. Traditional use is 2-3 applications daily after the initial burn has set; applied before further sun exposure, the oil itself, while soothing on already-sunburned skin, would theoretically increase photosensitivity on healthy skin.

Back to Table of Contents

Surgical Wound Recovery

Several clinical investigations have examined hypericum preparations for postoperative wound care, with the most rigorous evidence in:

Practical points described for surgical wound use:

Back to Table of Contents

Nerve-Pain Applications (Trigeminal Neuralgia, Post-Herpetic Neuralgia, Sciatica)

Traditional herbalists classify St. John's Wort as a nervine — an herb that nourishes and restores the nervous system — and have used both topical and oral preparations for various nerve-pain conditions for centuries. Modern research suggests hypericin and hyperforin do have analgesic and neuroprotective effects, though the strength of clinical evidence varies by condition.

Trigeminal neuralgia: severe lancinating facial pain along the trigeminal nerve distribution. Conventional first-line treatment is carbamazepine (an anticonvulsant), with surgical decompression for refractory cases. Topical hypericum oil massaged along the affected facial nerve distribution has been used adjunctively in European phytotherapy, with anecdotal reports of pain reduction. Rigorous trial evidence is limited.

Post-herpetic neuralgia (PHN): persistent nerve pain after a shingles outbreak (varicella zoster reactivation). Topical hypericum oil application along the affected dermatome has been used both for acute shingles lesions and for the resulting post-herpetic neuralgia. The combination of antiviral activity (during the acute outbreak) and anti-inflammatory/analgesic activity (for both acute pain and PHN) is biologically appealing. Conventional first-line treatments for PHN include topical lidocaine, capsaicin, gabapentin/pregabalin, and tricyclic antidepressants. See our Shingles page for more on this condition.

Sciatica and back pain: massaging hypericum oil into the lumbar region and along the sciatic distribution down the affected leg has been a traditional European remedy for sciatic pain. The combination of anti-inflammatory effect (reducing nerve root inflammation), analgesic effect (modulating nociceptive signaling), and muscular relaxant effect from the massage itself may contribute to reported benefit. Not a substitute for evaluation of underlying causes (disc herniation, spinal stenosis, etc.).

Diabetic peripheral neuropathy: small studies and case reports of topical hypericum for the burning, tingling, and pain of diabetic peripheral neuropathy in feet and hands. Traditional use is 2-3 applications daily, with massage to enhance penetration, and it is also used alongside conventional treatments (alpha-lipoic acid, acetyl-L-carnitine, gabapentin/pregabalin or duloxetine).

Intercostal neuralgia: nerve pain along an intercostal nerve distribution, often from rib injury, surgical scar, or shingles reactivation in a thoracic dermatome. Topical hypericum oil application along the painful nerve distribution has been documented in European phytotherapy.

Oral hypericum for neuropathic pain: hyperforin's effects on serotonin and norepinephrine reuptake parallel the mechanism of duloxetine, a serotonin-norepinephrine reuptake inhibitor with established efficacy for diabetic peripheral neuropathy and fibromyalgia. Theoretically, oral hypericum could produce similar analgesic effects, though dedicated trials in neuropathic pain are limited. The drug-interaction profile of oral hypericum (see Critical Drug Interactions deep-dive) often precludes its use in patients on conventional pain medications, gabapentin, pregabalin, or tricyclics.

Back to Table of Contents

Home Preparation of Traditional Infused Oil

The traditional Oleum Hyperici can be prepared at home from fresh hypericum flowers if you have access to a clean source (cultivated in your garden or wildcrafted from an unpolluted area). The classic recipe:

  1. Harvest: collect fresh hypericum flower buds and just-opened flowers around the summer solstice (late June to mid-July in the northern hemisphere, when bloom is at peak). Pick flowers in mid-morning after dew has dried but before peak afternoon sun. Aim for approximately 1 cup of fresh flower material per pint of finished oil
  2. Prepare: gently rinse the flowers to remove any insects or debris, then spread on a clean cloth to dry for 1-2 hours (not completely — the flowers are meant to be wilted but still containing their volatile oils)
  3. Crush lightly: gently crush the flowers in a mortar or with the back of a spoon to release the oil glands. The flowers should release a small amount of red juice when crushed — this is the hypericin
  4. Infuse: place the crushed flowers in a clean glass jar (mason jar or similar) and cover with cold-pressed extra-virgin olive oil to about 1 inch above the plant material. Stir gently to release any trapped air bubbles. Cover with cheesecloth or a clean paper towel secured with a rubber band (not a tight lid — you need some air exchange for the photodynamic processes to occur)
  5. Sun-cure: place the jar in a warm, sunny location (a south-facing windowsill in the northern hemisphere works well) for 4 to 6 weeks. The oil will gradually develop the characteristic deep red color as hypericin is extracted into the oil and undergoes photoactivation. Stir or invert the jar every few days to redistribute the flowers
  6. Strain and bottle: after 4-6 weeks, strain the oil through fine cheesecloth or a coffee filter into clean amber glass bottles (the amber glass protects the finished oil from continued light exposure, which would otherwise degrade the active compounds). Squeeze the spent flowers thoroughly to extract all infused oil. Store in a cool, dark place
  7. Shelf life: properly prepared and stored, the oil keeps for 1-2 years. Discard if it develops a rancid smell, mold, or off color

The finished oil should be a deep, clear crimson-red color — a properly cured oil is dramatically darker than commercial preparations that have not been sun-cured. The intense color is the visible signature of high hypericin content.

Commercial hypericum oils are also sold. They differ in whether they are sun-cured or heat-extracted, in color, and in packaging (amber glass protects the finished oil from light, as noted above).

Back to Table of Contents

Topical Cautions and Photosensitivity

Topical hypericum is generally well-tolerated, but several cautions apply:

Back to Table of Contents

Key Research Papers

  1. Schempp CM, Pelz K, Wittmer A, Schöpf E, Simon JC (1999). Antibacterial activity of hyperforin from St John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria. The Lancet, 353(9170):2129. The seminal hyperforin/MRSA paper. — PubMed PMID: 10382704
  2. Meruelo D, Lavie G, Lavie D (1988). Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. PNAS, 85(14):5230-4. The original hypericin antiviral discovery paper. — PubMed PMID: 2839837
  3. Lavie G et al. (1989). Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. PNAS, 86(15):5963-7. Hypericin antiviral mechanism elucidation. — PubMed PMID: 2548193
  4. Wood S, Huffman J, Weber N, Andersen D, North J, Murray B, Sidwell R, Hughes B (1990). Antiviral activity of naturally occurring anthraquinones and anthraquinone derivatives. Planta Medica, 56(6):651-2. Hypericin antiviral spectrum. — doi:10.1055/s-2006-961304
  5. Samadi S, Khadivzadeh T, Emami A, Moosavi NS, Tafaghodi M, Behnam HR (2010). The effect of Hypericum perforatum on the wound healing and scar of cesarean. Journal of Alternative and Complementary Medicine, 16(1):113-7. Postoperative cesarean wound trial: 144 women, three arms (hypericum ointment, placebo ointment, no treatment). — PubMed PMID: 20064022
  6. Reichling J, Weseler A, Saller R (2001). A current review of the antimicrobial activity of Hypericum perforatum L. Pharmacopsychiatry, 34 Suppl 1:S116-8. Antimicrobial activity review. — PubMed PMID: 11518059
  7. Schempp CM, Windeck T, Hezel S, Simon JC (2003). Topical treatment of atopic dermatitis with St. John's wort cream — a randomized, placebo controlled, double blind half-side comparison. Phytomedicine, 10 Suppl 4:31-7. Atopic dermatitis topical trial. — PubMed PMID: 12807340
  8. Süntar IP, Akkol EK, Yilmazer D, Baykal T, Kirmizibekmez H, Alper M, Yeşilada E (2010). Investigations on the in vivo wound healing potential of Hypericum perforatum L. Journal of Ethnopharmacology, 127(2):468-77. Animal wound models; hyperoside, isoquercitrin, rutin, (-)-epicatechin and hypericins identified as the active components. — PubMed PMID: 19833187
  9. Birt DF, Widrlechner MP, Hammer KD, Hillwig ML, Wei J, Kraus GA, Murphy PA, McCoy JA, Wurtele ES, Neighbors JD, Wiemer DF, Maury WJ, Price JP (2009). Hypericum in infection: identification of anti-viral and anti-inflammatory constituents. Pharmaceutical Biology, 47(8):774-782. Comprehensive antiviral/anti-inflammatory review. — PubMed PMID: 19907671
  10. Saddiqe Z, Naeem I, Maimoona A (2010). A review of the antibacterial activity of Hypericum perforatum L. Journal of Ethnopharmacology, 131(3):511-21. Antibacterial review. — PubMed PMID: 20659547
  11. Kacerovská D, Pizinger K, Majer F, Smíd F (2008). Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract — a pilot study. Photochemistry and Photobiology, 84(3):779-85. Hypericum PDT for skin cancer pilot: 34 patients. — PubMed PMID: 18179625
  12. Derbentseva NA, Mishenkova EL, Garagulia OD (1972). [Action of tannins from Hypericum perforatum L. on the influenza virus]. Mikrobiol Zh, 34(6):768-72. Early Soviet hypericum antiviral research. — PubMed PMID: 4667029
  13. Gulick RM, McAuliffe V, Holden-Wiltse J, Crumpacker C, Liebes L, Stein DS, Meehan P, Hussey S, Forcht J, Valentine FT (1999). Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. Annals of Internal Medicine, 130(6):510-4. 30 patients; 16 stopped early for toxic effects; no antiretroviral activity. — PubMed PMID: 10075619
  14. Jacobson JM, Feinman L, Liebes L, Ostrow N, Koslowski V, Tobia A, Cabana BE, Lee D, Spritzler J, Prince AM (2001). Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's wort plant, in patients with chronic hepatitis C virus infection. Antimicrobial Agents and Chemotherapy, 45(2):517-24. Phototoxicity and no detectable anti-HCV activity. — PubMed PMID: 11158749
  15. Vakili F, Mirmohammadaliei M, Montazeri A, Farokhi M, Minaee MB (2018). Impact of Hypericum Perforatum Ointment on Perineal Pain Intensity Following Episiotomy: a Randomized Placebo-Controlled Trial. Journal of Caring Sciences, 7(4):205-211. 98 women, ointment twice daily for ten days. — PubMed PMID: 30607361
  16. Hajhashemi M, Ghanbari Z, Movahedi M, Rafieian M, Keivani A, Haghollahi F (2018). The effect of Achillea millefolium and Hypericum perforatum ointments on episiotomy wound healing in primiparous women. Journal of Maternal-Fetal & Neonatal Medicine, 31(1):63-69. 140 women, four groups. — PubMed PMID: 28027682
  17. Hejazi Niyaki SA, Bayat Y (2026). Hypericum perforatum for diabetes-related wounds: A structured critical review of evidence and translational barriers. Journal of Tissue Viability, 36(1):101083. Nine animal studies and three uncontrolled human reports; clinical efficacy unproven. — PubMed PMID: 42994168
  18. Hamedi ZS, Manafi A, Hashemi SS, Mehrabani D, Seddighi A, Tanideh N, Mokhtari M (2024). Healing Effect of Hypericum perforatum in Burn Injuries. World Journal of Plastic Surgery, 13(3):57-65. Burn model in 60 rats. — PubMed PMID: 39665012

PubMed Topic Searches

  1. PubMed: Hypericum topical wound healing
  2. PubMed: Hypericin photodynamic therapy
  3. PubMed: Hyperforin antibacterial
  4. PubMed: Hypericum HSV
  5. PubMed: Hypericum burns
  6. PubMed: Hypericin HPV warts

Back to Table of Contents

Connections

Back to Table of Contents